Miv Therapeutics, Inc. (IVT) Misses Q3 EPS by 5c

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of ($0.01), $0.05 worse than the analyst estimate of $0.04.

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Infleqtion raises Q2 revenue to $13.5M after contract restatement